Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pasireotide LA by Recordati for Hyperprolactinaemia: Likelihood of Approval
Pasireotide LA is under clinical development by Recordati and currently in Phase II for Hyperprolactinaemia. According to GlobalData, Phase II...